Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

nifekalant

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
BACKGROUND Additional ablation of complex fractionated atrial electrograms (CFAE) after pulmonary vein isolation (PVI) has been… Expand
Is this relevant?
2013
2013
PurposeNifekalant is a pure potassium channel blocker that has been used to treat ventricular tachyarrhythmias since 1999 in… Expand
  • table 1
  • table 2
Is this relevant?
2010
2010
OBJECTIVE To compare the efficacy of nifekalant and amiodarone in the treatment of cardiac arrest in a porcine model. METHODS… Expand
Is this relevant?
2010
2010
BACKGROUND In Japan, intravenous nifekalant (NIF) was often used for direct current cardioversion-resistant ventricular… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2010
2010
OBJECTIVE To compare the efficacy and safety of nifekalant, a pure class III anti-arrhythmic drug, and lidocaine in patients with… Expand
  • table 1
  • table 2
  • table 3
  • table 5
Is this relevant?
2008
2008
We assessed several pharmacological effects on electrocardiogram parameters and effective refractory period (ERP) in a patient… Expand
  • figure 1
  • table I
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Drug-induced block of cardiac hERG K+ channels causes acquired long QT syndrome. Here, we characterized the molecular mechanism… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
2006
2006
BACKGROUND Although nifekalant is a class III antiarrhythmic agent without negative inotropic activity, its effect in patients… Expand
Is this relevant?
2005
2005
BACKGROUND Spiral re-entry plays the principal role in the genesis of ventricular tachycardia and ventricular fibrillation (VT/VF… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2005
2005
BACKGROUND Because class I anti-arrhythmic drugs sometimes suppress cardiac function caused by their negative inotropic effects… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?